• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者皮肤表现的患病率及临床意义

The Prevalence and Clinical Significance of Skin Manifestations in Parkinson's Disease Patients.

作者信息

Iyidal Ayşegül Yalçınkaya, Erduran Funda, Hayran Yıldız, Karadağ Yeşim Sücüllü

机构信息

Department of Dermatology, Ankara Bilkent City Hospital, Çankaya/Ankara, Türkiye.

Department of Neurology, University of Health Sciences, Ankara Bilkent City Hospital, Çankaya/Ankara, Türkiye.

出版信息

Dermatol Pract Concept. 2024 Oct 30;14(4):e2024241. doi: 10.5826/dpc.1404a241.

DOI:10.5826/dpc.1404a241
PMID:39652919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11620005/
Abstract

BACKGROUND

Parkinson's disease (PD) is primarily characterized by motor symptoms, but non-motor symptoms, including skin manifestations, are increasingly recognized. These remain underexplored despite their potential impact on quality of life.

OBJECTIVES

This study aimed to evaluate the prevalence and clinical features of skin findings in PD patients, with a focus on identifying potential pathogenetic links between dermatological conditions and PD.

METHODS

A total of 215 PD patients were included. Comprehensive dermatological examinations were performed, and demographic and clinical data were collected. Statistical analysis was conducted using SPSS 23.0, with significance set at P < 0.05.

RESULTS

Skin conditions were found in 92.1% of PD patients. Xerosis, seborrheic dermatitis, and hyperhidrosis were the most common findings. Pre-PD xerosis was associated with an earlier stage of PD (P = 0.001). Use of PD medications, such as levodopa/carbidopa/entacapone, was linked to a lower incidence of seborrheic dermatitis (P = 0.040). A significant correlation was also noted between rosacea and cherry angioma (P = 0.01).

CONCLUSION

Dermatological conditions are prevalent in PD and may precede its motor symptoms. Skin assessments could aid early diagnosis and management of PD, highlighting the need for further research on their pathogenetic mechanisms.

摘要

背景

帕金森病(PD)主要以运动症状为特征,但包括皮肤表现在内的非运动症状越来越受到关注。尽管这些症状对生活质量有潜在影响,但仍未得到充分研究。

目的

本研究旨在评估帕金森病患者皮肤表现的患病率和临床特征,重点是确定皮肤病与帕金森病之间潜在的发病机制联系。

方法

共纳入215例帕金森病患者。进行了全面的皮肤科检查,并收集了人口统计学和临床数据。使用SPSS 23.0进行统计分析,显著性设定为P<0.05。

结果

92.1%的帕金森病患者存在皮肤问题。皮肤干燥、脂溢性皮炎和多汗症是最常见的表现。帕金森病发病前的皮肤干燥与帕金森病的早期阶段相关(P = 0.001)。使用左旋多巴/卡比多巴/恩他卡朋等帕金森病药物与脂溢性皮炎的较低发病率相关(P = 0.040)。酒渣鼻和樱桃状血管瘤之间也存在显著相关性(P = 0.01)。

结论

皮肤病在帕金森病中很常见,可能先于其运动症状出现。皮肤评估有助于帕金森病的早期诊断和管理,凸显了对其发病机制进行进一步研究的必要性。

相似文献

1
The Prevalence and Clinical Significance of Skin Manifestations in Parkinson's Disease Patients.帕金森病患者皮肤表现的患病率及临床意义
Dermatol Pract Concept. 2024 Oct 30;14(4):e2024241. doi: 10.5826/dpc.1404a241.
2
Dermatological Manifestations of Parkinson's Disease: Clues for Diagnosis.帕金森病的皮肤表现:诊断线索
Cureus. 2020 Oct 7;12(10):e10836. doi: 10.7759/cureus.10836.
3
Skin disorders in Parkinson's disease: potential biomarkers and risk factors.帕金森病中的皮肤疾病:潜在生物标志物和风险因素。
Clin Cosmet Investig Dermatol. 2017 Mar 9;10:87-92. doi: 10.2147/CCID.S130319. eCollection 2017.
4
Parkinson's Disease and Its Dermatological Associations: Is Your Skin Whispering You a Diagnosis?帕金森病及其皮肤关联:你的皮肤在向你悄悄诉说诊断结果吗?
Cureus. 2020 Aug 22;12(8):e9933. doi: 10.7759/cureus.9933.
5
Seborrheic Dermatitis Is Related to Motor Symptoms in Parkinson's Disease.脂溢性皮炎与帕金森病的运动症状有关。
J Clin Neurol. 2022 Nov;18(6):628-634. doi: 10.3988/jcn.2022.18.6.628.
6
An open-label evaluation of the tolerability and safety of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off.对处于剂末现象的帕金森病患者使用息宁(卡比多巴、左旋多巴和恩他卡朋)的耐受性和安全性进行的开放标签评估。
J Neural Transm (Vienna). 2005 Feb;112(2):221-30. doi: 10.1007/s00702-004-0184-1. Epub 2004 Oct 22.
7
Levodopa/carbidopa/entacapone for the treatment of early Parkinson's disease: a meta-analysis.左旋多巴/卡比多巴/恩他卡朋治疗早期帕金森病:一项荟萃分析。
Neurol Sci. 2020 Aug;41(8):2045-2054. doi: 10.1007/s10072-020-04303-x. Epub 2020 Mar 11.
8
The efficacy of levodopa/carbidopa/entacapone on cognitive function in moderate to advanced Parkinson's disease and its relationship with peripheral inflammatory cytokines.左旋多巴/卡比多巴/恩他卡朋对中重度帕金森病认知功能的疗效及其与外周炎性细胞因子的关系
BMC Neurol. 2025 Mar 19;25(1):116. doi: 10.1186/s12883-025-04128-1.
9
Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson's disease.卡比多巴/左旋多巴/恩他卡朋:其在帕金森病治疗中地位的证据
Core Evid. 2010 Jul 27;5:1-10.
10
[Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study].[从传统左旋多巴直接转换为息宁(左旋多巴/卡比多巴/恩他卡朋)可改善帕金森病患者的生活质量:一项开放标签临床研究的结果]
Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(1):51-4.

本文引用的文献

1
Seborrheic Dermatitis Is Related to Motor Symptoms in Parkinson's Disease.脂溢性皮炎与帕金森病的运动症状有关。
J Clin Neurol. 2022 Nov;18(6):628-634. doi: 10.3988/jcn.2022.18.6.628.
2
Skin alpha-synuclein deposit patterns: A predictor of Parkinson's disease subtypes.皮肤α-突触核蛋白沉积模式:帕金森病亚型的预测因子。
EBioMedicine. 2022 Jun;80:104076. doi: 10.1016/j.ebiom.2022.104076. Epub 2022 May 26.
3
Parkinson's disease and cancer: a systematic review and meta-analysis of over 17 million participants.帕金森病与癌症:超过 1700 万参与者的系统评价和荟萃分析。
BMJ Open. 2021 Jul 2;11(7):e046329. doi: 10.1136/bmjopen-2020-046329.
4
Onset of Skin, Gut, and Genitourinary Prodromal Parkinson's Disease: A Study of 1.5 Million Veterans.皮肤、肠道和泌尿生殖系统前驱期帕金森病的发病:一项涉及 150 万退伍军人的研究。
Mov Disord. 2021 Sep;36(9):2094-2103. doi: 10.1002/mds.28636. Epub 2021 May 3.
5
Skin conditions in early Parkinson's disease.早期帕金森病的皮肤状况。
Parkinsonism Relat Disord. 2021 Mar;84:40-46. doi: 10.1016/j.parkreldis.2021.01.018. Epub 2021 Jan 29.
6
Parkinson's disease and skin.帕金森病与皮肤。
Parkinsonism Relat Disord. 2021 Jan;82:61-76. doi: 10.1016/j.parkreldis.2020.11.017. Epub 2020 Nov 20.
7
Dermatological Manifestations of Parkinson's Disease: Clues for Diagnosis.帕金森病的皮肤表现:诊断线索
Cureus. 2020 Oct 7;12(10):e10836. doi: 10.7759/cureus.10836.
8
Parkinson's Disease and Its Dermatological Associations: Is Your Skin Whispering You a Diagnosis?帕金森病及其皮肤关联:你的皮肤在向你悄悄诉说诊断结果吗?
Cureus. 2020 Aug 22;12(8):e9933. doi: 10.7759/cureus.9933.
9
Where and how alpha-synuclein pathology spreads in Parkinson's disease.帕金森病中 alpha-synuclein 病理学的传播位置和方式。
Neuropathology. 2020 Oct;40(5):415-425. doi: 10.1111/neup.12691. Epub 2020 Aug 4.
10
Prevalence of actinic keratosis in patients attending the dermatology outpatient clinic.皮肤科门诊患者日光性角化病的患病率。
Medicine (Baltimore). 2019 Jul;98(28):e16465. doi: 10.1097/MD.0000000000016465.